FI960567A0 - Monoklonal antikropp som inducerar apoptosis - Google Patents
Monoklonal antikropp som inducerar apoptosisInfo
- Publication number
- FI960567A0 FI960567A0 FI960567A FI960567A FI960567A0 FI 960567 A0 FI960567 A0 FI 960567A0 FI 960567 A FI960567 A FI 960567A FI 960567 A FI960567 A FI 960567A FI 960567 A0 FI960567 A0 FI 960567A0
- Authority
- FI
- Finland
- Prior art keywords
- antibody
- monoclonal antibody
- induces apoptosis
- myelocytic
- cell
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP05242110 | 1993-09-03 | ||
| PCT/JP1994/001453 WO1995006748A1 (fr) | 1993-09-03 | 1994-09-02 | Anticorps monoclonal permettant d'induire une apoptose |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FI960567A FI960567A (sv) | 1996-02-07 |
| FI960567A0 true FI960567A0 (sv) | 1996-02-07 |
Family
ID=17084452
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI960567A FI960567A0 (sv) | 1993-09-03 | 1996-02-07 | Monoklonal antikropp som inducerar apoptosis |
Country Status (19)
| Country | Link |
|---|---|
| US (4) | US5840344A (sv) |
| EP (1) | EP0721015B1 (sv) |
| KR (1) | KR100241863B1 (sv) |
| CN (1) | CN1046314C (sv) |
| AT (1) | ATE280835T1 (sv) |
| AU (1) | AU692466B2 (sv) |
| CA (1) | CA2169950A1 (sv) |
| CZ (1) | CZ294359B6 (sv) |
| DE (1) | DE69434097T2 (sv) |
| FI (1) | FI960567A0 (sv) |
| HU (1) | HU222989B1 (sv) |
| NO (1) | NO960684D0 (sv) |
| PL (1) | PL181783B1 (sv) |
| RU (1) | RU2202615C2 (sv) |
| SK (1) | SK281964B6 (sv) |
| TW (1) | TW426687B (sv) |
| UA (1) | UA50708C2 (sv) |
| WO (1) | WO1995006748A1 (sv) |
| ZA (1) | ZA946767B (sv) |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE280835T1 (de) * | 1993-09-03 | 2004-11-15 | Chugai Pharmaceutical Co Ltd | Apoptose induzierender monoklonaler antikörper |
| AU2232597A (en) * | 1996-03-06 | 1997-09-22 | Chugai Seiyaku Kabushiki Kaisha | Method of screening apoptosis inducing substances |
| US6828426B1 (en) | 1996-07-15 | 2004-12-07 | Chugai Seiyaku Kabushiki Kaisha | VEGF-like factor |
| DE69839492D1 (de) * | 1997-09-11 | 2008-06-26 | Chugai Pharmaceutical Co Ltd | Monoklonale antikörper zur apoptosis-induzierung |
| US7531643B2 (en) * | 1997-09-11 | 2009-05-12 | Chugai Seiyaku Kabushiki Kaisha | Monoclonal antibody inducing apoptosis |
| EP1167388A4 (en) * | 1999-03-10 | 2002-05-29 | Chugai Pharmaceutical Co Ltd | APOPTOSE INDUCING SINGLE STRING FV |
| US7696325B2 (en) | 1999-03-10 | 2010-04-13 | Chugai Seiyaku Kabushiki Kaisha | Polypeptide inducing apoptosis |
| US20040058393A1 (en) * | 2000-04-17 | 2004-03-25 | Naoshi Fukishima | Agonist antibodies |
| DE60133479T2 (de) | 2000-10-20 | 2009-04-16 | Chugai Seiyaku K.K. | Modifizierter tpo-agonisten antikörper |
| CN1308447C (zh) * | 2000-10-20 | 2007-04-04 | 中外制药株式会社 | 低分子化的激动剂抗体 |
| US7195771B1 (en) | 2000-11-21 | 2007-03-27 | Kimberly-Clark Worldwide, Inc. | Water-soluble lotions for paper products |
| AU2002361642A1 (en) * | 2001-11-16 | 2003-06-10 | The University Of Tennessee Research Corporation | Recombinant antibody fusion proteins and methods for detection of apoptotic cells |
| ATE414105T1 (de) | 2002-10-11 | 2008-11-15 | Chugai Pharmaceutical Co Ltd | Zelltod-induzierender wirkstoff |
| JP2004279086A (ja) * | 2003-03-13 | 2004-10-07 | Konica Minolta Holdings Inc | 放射線画像変換パネル及び放射線画像変換パネルの製造方法 |
| EP1609803A4 (en) * | 2003-03-31 | 2006-05-24 | Chugai Pharmaceutical Co Ltd | MODIFIED ANTIBODY AGAINST CD22 AND ITS USE |
| AU2004297109A1 (en) * | 2003-12-12 | 2005-06-23 | Chugai Seiyaku Kabushiki Kaisha | Cell death inducing agent |
| TW200530269A (en) | 2003-12-12 | 2005-09-16 | Chugai Pharmaceutical Co Ltd | Anti-Mpl antibodies |
| WO2005056602A1 (ja) * | 2003-12-12 | 2005-06-23 | Chugai Seiyaku Kabushiki Kaisha | アゴニスト活性を有する改変抗体のスクリーニング方法 |
| TW200530266A (en) * | 2003-12-12 | 2005-09-16 | Chugai Pharmaceutical Co Ltd | Method of reinforcing antibody activity |
| US9493569B2 (en) | 2005-03-31 | 2016-11-15 | Chugai Seiyaku Kabushiki Kaisha | Structural isomers of sc(Fv)2 |
| EP1927367A4 (en) * | 2005-05-18 | 2009-08-12 | Univ Tokushima | NOVEL PHARMACEUTICAL AGENT BASED ON AN ANTI-HLA ANTIBODY |
| KR101360671B1 (ko) | 2005-06-10 | 2014-02-07 | 추가이 세이야쿠 가부시키가이샤 | ｓｃ（Ｆｖ）２를 함유하는 의약조성물 |
| AU2006256041B2 (en) * | 2005-06-10 | 2012-03-29 | Chugai Seiyaku Kabushiki Kaisha | Stabilizer for protein preparation comprising meglumine and use thereof |
| WO2007100892A2 (en) * | 2006-02-28 | 2007-09-07 | The Board Of Trustees Of The Leland Stanford Junior University | Trojan horse immunotherapy |
| AR061986A1 (es) * | 2006-07-13 | 2008-08-10 | Chugai Pharmaceutical Co Ltd | Agentes inductores de muerte celular |
| CL2008000719A1 (es) * | 2007-03-12 | 2008-09-05 | Univ Tokushima Chugai Seiyaku | Agente terapeutico para cancer resistente a agentes quimioterapeuticos que comprende un anticuerpo que reconoce hla de clase i como ingrediente activo; composicion farmaceutica que comprende dicho anticuerpo; y metodo para tratar cancer resistente a |
| KR20170108946A (ko) | 2014-12-05 | 2017-09-27 | 메모리얼 슬로안-케터링 캔서 센터 | Fc 수용체-유사 5를 표적화하는 키메라 항원 수용체 및 그의 용도 |
| BR112018011336A2 (pt) | 2015-12-04 | 2018-12-04 | Memorial Sloan-Kettering Cancer Center | anticorpo anti-fcrl5 isolado ou um fragmento de ligação ao antígeno do mesmo, anticorpo scfv anti-fcrl5 isolado, anticorpo isolado ou porção de ligação ao antígeno do mesmo, composição, imunoconjugado, molécula biespecífica, ácido nucleico isolado, vetor de expressão, célula hospedeira, método para detectar fcrl5 em uma célula ou tecido inteiro, método para tratar câncer em um indivíduo, uso do anticorpo ou fragmento de ligação ao antígeno do mesmo, kit para tratar câncer |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE280835T1 (de) * | 1993-09-03 | 2004-11-15 | Chugai Pharmaceutical Co Ltd | Apoptose induzierender monoklonaler antikörper |
| AU2232597A (en) * | 1996-03-06 | 1997-09-22 | Chugai Seiyaku Kabushiki Kaisha | Method of screening apoptosis inducing substances |
| DE69839492D1 (de) * | 1997-09-11 | 2008-06-26 | Chugai Pharmaceutical Co Ltd | Monoklonale antikörper zur apoptosis-induzierung |
| EP1167388A4 (en) * | 1999-03-10 | 2002-05-29 | Chugai Pharmaceutical Co Ltd | APOPTOSE INDUCING SINGLE STRING FV |
-
1994
- 1994-09-02 AT AT94925618T patent/ATE280835T1/de not_active IP Right Cessation
- 1994-09-02 ZA ZA946767A patent/ZA946767B/xx unknown
- 1994-09-02 DE DE69434097T patent/DE69434097T2/de not_active Expired - Fee Related
- 1994-09-02 WO PCT/JP1994/001453 patent/WO1995006748A1/ja active IP Right Grant
- 1994-09-02 US US08/605,059 patent/US5840344A/en not_active Expired - Lifetime
- 1994-09-02 CA CA002169950A patent/CA2169950A1/en not_active Abandoned
- 1994-09-02 CZ CZ1996617A patent/CZ294359B6/cs not_active IP Right Cessation
- 1994-09-02 SK SK255-96A patent/SK281964B6/sk unknown
- 1994-09-02 HU HU9600206A patent/HU222989B1/hu not_active IP Right Cessation
- 1994-09-02 PL PL94313260A patent/PL181783B1/pl not_active IP Right Cessation
- 1994-09-02 AU AU75466/94A patent/AU692466B2/en not_active Ceased
- 1994-09-02 KR KR1019960700821A patent/KR100241863B1/ko not_active IP Right Cessation
- 1994-09-02 CN CN94193260A patent/CN1046314C/zh not_active Expired - Fee Related
- 1994-09-02 EP EP94925618A patent/EP0721015B1/en not_active Expired - Lifetime
- 1994-09-02 RU RU96107203/13A patent/RU2202615C2/ru not_active IP Right Cessation
- 1994-09-02 UA UA96030813A patent/UA50708C2/uk unknown
- 1994-11-19 TW TW083110887A patent/TW426687B/zh not_active IP Right Cessation
-
1996
- 1996-02-07 FI FI960567A patent/FI960567A0/sv not_active Application Discontinuation
- 1996-02-21 NO NO960684A patent/NO960684D0/no not_active Application Discontinuation
-
1998
- 1998-09-17 US US09/154,498 patent/US6267959B1/en not_active Expired - Lifetime
-
2000
- 2000-12-15 US US09/736,146 patent/US6759043B2/en not_active Expired - Fee Related
-
2003
- 2003-03-03 US US10/376,628 patent/US20030147894A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| RU2202615C2 (ru) | 2003-04-20 |
| UA50708C2 (uk) | 2002-11-15 |
| EP0721015A1 (en) | 1996-07-10 |
| FI960567A (sv) | 1996-02-07 |
| EP0721015B1 (en) | 2004-10-27 |
| US6267959B1 (en) | 2001-07-31 |
| KR100241863B1 (ko) | 2000-03-02 |
| US20030147894A1 (en) | 2003-08-07 |
| US5840344A (en) | 1998-11-24 |
| SK25596A3 (en) | 1996-10-02 |
| CN1046314C (zh) | 1999-11-10 |
| US20010001712A1 (en) | 2001-05-24 |
| ZA946767B (en) | 1995-04-03 |
| PL181783B1 (pl) | 2001-09-28 |
| US6759043B2 (en) | 2004-07-06 |
| HU222989B1 (hu) | 2004-01-28 |
| CZ294359B6 (cs) | 2004-12-15 |
| CN1130405A (zh) | 1996-09-04 |
| AU692466B2 (en) | 1998-06-11 |
| WO1995006748A1 (fr) | 1995-03-09 |
| ATE280835T1 (de) | 2004-11-15 |
| CZ61796A3 (en) | 1996-06-12 |
| HUT74594A (en) | 1997-01-28 |
| NO960684L (no) | 1996-02-21 |
| DE69434097T2 (de) | 2006-02-02 |
| CA2169950A1 (en) | 1995-03-09 |
| DE69434097D1 (de) | 2004-12-02 |
| NO960684D0 (no) | 1996-02-21 |
| HU9600206D0 (en) | 1996-03-28 |
| TW426687B (en) | 2001-03-21 |
| PL313260A1 (en) | 1996-06-24 |
| AU7546694A (en) | 1995-03-22 |
| EP0721015A4 (en) | 1999-03-31 |
| SK281964B6 (sk) | 2001-09-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI960567A0 (sv) | Monoklonal antikropp som inducerar apoptosis | |
| DE69321218T2 (de) | Klonierung und expression von humanisierten monoklonalen antikörpern gegen menschliches interleukin-4 | |
| NO20001238L (no) | Monoklonalt antistoff som induserer apoptose | |
| NO2006008I1 (no) | Natalizumab, anti alfa-4 integrin humanized monoclonal antibody | |
| DE69532889D1 (de) | Interleukin-5-spezifische rekombinante antikörper | |
| DE68914244T2 (de) | Monoklonaler Antikörper. | |
| ATE160575T1 (de) | Für toxin b von clostridium difficile spezifische monoklonale antikörper | |
| NO944247D0 (no) | Anti-reseptormidler mot vitamin B12/transcobamin-II-reseptor | |
| ATE206621T1 (de) | Il-8 antagonisten zur behandlung von asthma | |
| DE3580482D1 (de) | Monoklonale antikoerper und immunisierung damit. | |
| DK49291A (da) | Gramnegativ-bakterieendotoxinblokerende, monoklonale antistoffer | |
| ATE318844T1 (de) | Wachstumsinhibierende agenzien gegen vitamin b12 bindungsstellen von transcobalamin-ii | |
| NO894555L (no) | Monoklonalt antistoff som spesifikt gjenkjenner n-glycolyl type gm2, hybridom som produserer antistoff og fremgangsmaate for fremstilling av hybridomet. | |
| ATE136469T1 (de) | Neue verwendung eines monoklonalen antikörpers | |
| IT1254315B (it) | Anticorpi monoclonali anti-idiotipici diretti contro anticorpi anti-tnf. | |
| ES2051870T3 (es) | Anticuerpo monoclonal capaz de suprimir la proliferacion de linfocitos t. | |
| DE68916088T2 (de) | Anti-CPBII-monoklonaler Antikörper. | |
| ATE58173T1 (de) | Monoklonale antikoerper und immunisierung damit. | |
| NO960683L (no) | Monoklonalt antistoff som gjenkjenner interstitialcelle-overflateantigen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD | Application lapsed |